ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TXMD TherapeuticsMD Inc

2.03
0.05 (2.53%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 10,661
Bid Price 2.01
Ask Price 2.08
News (1)
Day High 2.08

Low
1.84

52 Week Range

High
4.35

Day Low 1.98
Share Name Share Symbol Market Stock Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.05 2.53% 2.03 16:52:11
Open Price Low Price High Price Close Price Previous Close
1.98 1.98 2.08 2.03 1.98
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
277 10,661 US$ 2.01 US$ 21,417 - 1.84 - 4.35
Last Trade Type Quantity Price Currency
17:52:08 1 US$ 2.03 USD

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
21.57M 10.58M - 1.3M -10.28M -0.97 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

TherapeuticsMD News

Date Time Source News Article
6/14/202416:00Edgar (US Regulatory)Form AW - Amendment Withdrawal Request
5/10/202415:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/10/202415:15Edgar (US Regulatory)Form 8-K - Current report
5/10/202415:05Business WireTherapeuticsMD Announces First Quarter 2024 Financial..
3/29/202415:00Business WireTherapeuticsMD Announces Full Year 2023 Financial Results
12/07/202315:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/06/202310:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/17/202308:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of..
11/17/202308:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/14/202315:05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial..
8/21/202315:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
8/21/202315:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No TXMD Message Board. Create One! See More Posts on TXMD Message Board See More Message Board Posts

Historical TXMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.02082.171.962.0511,2800.00920.46%
1 Month2.132.251.962.1211,372-0.10-4.69%
3 Months2.362.39351.842.0817,840-0.33-13.98%
6 Months2.252.751.842.2319,107-0.22-9.78%
1 Year3.954.351.842.7720,637-1.92-48.61%
3 Years1.3211.690.15031.022,010,0880.7153.79%
5 Years2.5611.690.15031.493,487,392-0.53-20.70%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Your Recent History

Delayed Upgrade Clock